What is the recommended way to write the cause of death in cases of intraparenchymal (within the brain tissue) bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Write Cause of Death in Intraparenchymal Bleeding

When documenting cause of death from intraparenchymal bleeding, specify the anatomic location (e.g., "intraparenchymal hemorrhage - basal ganglia"), the underlying etiology when known (e.g., hypertensive, traumatic, coagulopathic), and any contributing factors such as anticoagulation status or coagulopathy.

Essential Components of Death Certificate Documentation

Primary Cause of Death Statement

  • Use the term "intraparenchymal hemorrhage" or "intracerebral hemorrhage" rather than generic terms like "brain hemorrhage" or "stroke" to provide anatomic specificity 1, 2.

  • Specify the exact anatomic location: deep/ganglionic (basal ganglia, thalamus), lobar (frontal, parietal, temporal, occipital), cerebellar, or brain stem 1.

  • Include hemorrhage volume when available, as volumes >30 mL in supratentorial locations or >3 cm in cerebellar locations indicate higher mortality risk 3.

Underlying Etiology Documentation

The immediate cause should be followed by the underlying pathophysiological mechanism:

  • For hypertensive hemorrhages: Document as "intraparenchymal hemorrhage due to hypertensive vasculopathy" when located in typical deep locations (basal ganglia, thalamus, pons, cerebellum) 4, 1.

  • For coagulopathic hemorrhages: Specify "intraparenchymal hemorrhage due to [specific anticoagulant]" or "intraparenchymal hemorrhage due to coagulopathy secondary to [underlying condition]" 4.

  • For traumatic hemorrhages: Document as "traumatic intraparenchymal hemorrhage" to distinguish from spontaneous bleeding 4.

  • For structural lesions: Include "intraparenchymal hemorrhage secondary to [arteriovenous malformation/aneurysm/tumor/cerebral amyloid angiopathy]" when identified 4, 5.

Contributing Factors Section

Document relevant contributing conditions in the appropriate section of the death certificate:

  • Anticoagulation status (warfarin, direct oral anticoagulants, antiplatelet agents) 6, 7.

  • Coagulation disorders (thrombocytopenia, hemophilia, factor deficiencies) 4, 5.

  • Chronic hypertension as a contributing factor even if not the immediate cause 1.

  • Cerebral amyloid angiopathy for lobar hemorrhages in elderly patients 4, 5.

Mechanism of Death Documentation

Immediate Physiological Cause

Specify the terminal event that directly preceded death:

  • Transtentorial herniation secondary to mass effect from intraparenchymal hemorrhage 3.

  • Brainstem compression from cerebellar hemorrhage with obstructive hydrocephalus 3.

  • Elevated intracranial pressure refractory to medical management 8, 3.

  • Intraventricular extension with acute hydrocephalus when present 6.

Complications Leading to Death

Document secondary complications when they contributed to death:

  • Hemorrhagic expansion documented on follow-up imaging (specify volume increase of >6-12.5 mL or >20-33% relative increase) 4.

  • Cerebral edema with midline shift 6, 1.

  • Seizures with status epilepticus 6.

  • Medical complications (aspiration pneumonia, pulmonary embolism, cardiac complications) 9.

Temporal Sequence Documentation

Time Course Specification

  • Document time from symptom onset to death, as this provides epidemiological data 3.

  • Note if death occurred within 24 hours (hyperacute phase), 24-72 hours (acute phase), or beyond 72 hours 4.

  • Specify if hemorrhage expansion was documented on follow-up imaging at 24 hours 4, 8.

Category Classification for Statistical Purposes

Distinguish Between Four Main Categories

The death certificate should allow classification into one of four categories for public health surveillance 4:

  1. Noncoagulopathic spontaneous intraparenchymal hemorrhage - most commonly hypertensive 4.

  2. Coagulopathic spontaneous intraparenchymal hemorrhage - related to anticoagulation or coagulation disorders 4.

  3. Noncoagulopathic traumatic intraparenchymal hemorrhage 4.

  4. Coagulopathic traumatic intraparenchymal hemorrhage 4.

Common Pitfalls to Avoid

  • Avoid using vague terms like "cerebrovascular accident" or "stroke" without specifying hemorrhagic nature and location 1, 2.

  • Do not omit anticoagulation status when present, as this is critical for epidemiological tracking and quality improvement 6, 7.

  • Do not list only "increased intracranial pressure" as the cause without specifying the underlying hemorrhage 8.

  • Avoid listing "coma" or "respiratory failure" as the primary cause when these are terminal events from the hemorrhage 9.

  • Do not use "intracerebral bleeding" and "intraparenchymal hemorrhage" interchangeably without recognizing that intracerebral hemorrhage specifically refers to bleeding within brain parenchyma, excluding subdural, epidural, or subarachnoid spaces 4, 1.

Severity Indicators to Include

Document objective severity measures when available:

  • Glasgow Coma Scale score at presentation and at time of death 8.

  • NIHSS score if documented 8.

  • Presence of intraventricular extension 6.

  • Midline shift measurement in millimeters 4.

  • Documented intracranial pressure readings if monitored 8.

References

Research

Update in intracerebral hemorrhage.

The Neurohospitalist, 2011

Guideline

Manejo Inmediato de la Hemorragia Intraparenquimatosa Espontánea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Causas y Mecanismos de Hemorragias Intracerebrales Espontáneas Parietales

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Scoring Systems and Monitoring for Intracerebral Hemorrhage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intracranial hemorrhage.

American journal of respiratory and critical care medicine, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.